Tinus Group

Recently, Tinus Group, an international enterprise specializing in health product R&D and manufacturing, has officially disclosed its global strategic layout and core business progress to the public. Since its establishment in September 2022, the group has rapidly built a worldwide health product supply chain system, dedicated to providing partners with one-stop health product solutions.

Dinnas Group operates with Hong Kong, China as its global hub, establishing research centers in the United States, Canada, China, and other regions, and has formed a core R&D team composed of researchers, nutritionists, and health experts from multiple countries. The group extensively applies artificial intelligence and big data technologies, leveraging deep learning models based on the Transformer framework to significantly shorten R&D cycles and accurately predict product development directions. Additionally, through collaboration with Canada's UltraSpec Lab in developing supramolecular drug delivery technology, it has significantly enhanced drug targeting and therapeutic efficacy, injecting new momentum into health product innovation.

In terms of manufacturing, Cinnas Group has established production bases in the United States, Japan, Canada, Hong Kong, China, and other countries and regions that comply with international certification standards such as GMP, ISO, and HACCP. This enables large-scale production of all dosage forms of health products including soft capsules, hard capsules, tablets, powders, gummies, oral liquids, and drops. The group strictly controls quality management throughout the entire chain from raw material selection, production processing to finished product packaging, while introducing third-party testing mechanisms such as SGS and UL to ensure product quality meets pharmaceutical-grade standards.

Cinnas has established six core business units globally, including R&D centers, production facilities, raw material selection centers, quality testing centers, sales hubs, and big data centers. Its sales network spans the United States, Thailand, South Africa, Hungary, France, Germany, and other countries, with a dedicated China office in Shenzhen that further enhances global market responsiveness.

Cinnas Group said that in the future, it will continue to deepen the integration of global resources and scientific research cooperation, continue to improve the technological content and health value of products, and devote itself to providing global consumers with more diversified and accurate health product choices, and practice the corporate vision of "starting from nutrition, sharing health and growing together".